IL238245A0 - Scavenging of small interfering RNA and micro-RNA through nano-sized reactive hydrogels that destroy membranes - Google Patents

Scavenging of small interfering RNA and micro-RNA through nano-sized reactive hydrogels that destroy membranes

Info

Publication number
IL238245A0
IL238245A0 IL238245A IL23824515A IL238245A0 IL 238245 A0 IL238245 A0 IL 238245A0 IL 238245 A IL238245 A IL 238245A IL 23824515 A IL23824515 A IL 23824515A IL 238245 A0 IL238245 A0 IL 238245A0
Authority
IL
Israel
Prior art keywords
rna
nanoscalle
disruptive
hydrogels
responsive
Prior art date
Application number
IL238245A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of IL238245A0 publication Critical patent/IL238245A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL238245A 2012-10-14 2015-04-12 Scavenging of small interfering RNA and micro-RNA through nano-sized reactive hydrogels that destroy membranes IL238245A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261713610P 2012-10-14 2012-10-14
PCT/US2013/064887 WO2014059430A1 (en) 2012-10-14 2013-10-14 Delivery of small interfering rna and micro rna through membrane-disruptive, responsive nanoscalle hydrogels

Publications (1)

Publication Number Publication Date
IL238245A0 true IL238245A0 (en) 2015-06-30

Family

ID=49510546

Family Applications (1)

Application Number Title Priority Date Filing Date
IL238245A IL238245A0 (en) 2012-10-14 2015-04-12 Scavenging of small interfering RNA and micro-RNA through nano-sized reactive hydrogels that destroy membranes

Country Status (6)

Country Link
US (1) US20150216814A1 (enExample)
EP (1) EP2906242A1 (enExample)
JP (1) JP2016500681A (enExample)
CA (1) CA2888135A1 (enExample)
IL (1) IL238245A0 (enExample)
WO (1) WO2014059430A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016073706A1 (en) * 2014-11-06 2016-05-12 Board Of Regents, The University Of Texas System Delivery of small interfering rna and micro rna through nanogels containing hydrophobic pseudo-peptides
CA3002786C (en) * 2015-10-30 2021-09-07 Bonac Corporation Composition stably containing single-stranded nucleic acid molecule that suppresses expression of tgf-.beta.1 gene

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060678A (en) * 1975-02-11 1977-11-29 Plastomedical Sciences, Inc. Cationic hydrogels based on hydroxyalkyl acrylates and methacrylates
JP3713841B2 (ja) * 1996-10-08 2005-11-09 荒川化学工業株式会社 カチオン性微粒子ゲルおよびその製造方法
US7378479B2 (en) * 2002-09-13 2008-05-27 Lubrizol Advanced Materials, Inc. Multi-purpose polymers, methods and compositions
EP2285358A1 (en) * 2008-06-03 2011-02-23 Novartis AG Pulsatile release of valsartan
GB201010831D0 (en) * 2010-06-28 2010-08-11 Ct Angewandte Nanotech Can A micellular combination comprising a nanoparticle and a plurality of surfmer ligands

Also Published As

Publication number Publication date
JP2016500681A (ja) 2016-01-14
US20150216814A1 (en) 2015-08-06
WO2014059430A1 (en) 2014-04-17
EP2906242A1 (en) 2015-08-19
CA2888135A1 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
IL269322B (en) Methylphenidate-medications, processes for their preparation and use
DK2922554T3 (en) Terminalt modificeret rna
EP3524074B8 (en) Item of clothing
SMT201700340T1 (it) Modulatori di enzimi modificanti metile, composizioni e loro utilizzo
IL238192A0 (en) Antibodies that recognize alpha-synuclei, preparations containing them and their uses
IL237625A0 (en) Antibodies against m-cam, preparations containing them and their uses
IL235004A0 (en) Antibodies against fgfr2, preparations containing them and their uses
EP2807992A4 (en) NECK SUPPORT
EP2880616A4 (en) DEVICE-TO-DEVICE ADVERTISEMENTS
EP2806874A4 (en) Specific chemical substances, compositions and methods
EP2916838A4 (en) CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND CERTAIN PROCESSES
EP2872964A4 (en) INTEGRATED MOBILE DESKTOP
ZA201405554B (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
EP2875132A4 (en) COOPERATIVE PRIMERS, PROBES AND APPLICATIONS THEREOF
GB201206455D0 (en) Gene expression
EP2805256A4 (en) PROVISION OF A CONTEXTUAL APPLICATION
IL238245A0 (en) Scavenging of small interfering RNA and micro-RNA through nano-sized reactive hydrogels that destroy membranes
EP2836858A4 (en) COUPLING RING, METHODS, AND APPLICATIONS
PL2725237T3 (pl) Membrana i układ pojemnika
WO2014093305A3 (en) Micrornas and uses thereof
GB201210756D0 (en) Analysis of small RNA
AU4997P (en) C3IZI203 Zea mays
AU4995P (en) 01INL1 Zea mays
AU4994P (en) 01DKD2 Zea mays
AU4996P (en) 87DUA5 Zea mays